According to the World Health Organization, coronary heart disease kills more people each year in high, middle and low income countries alike than any other disease. The 2012 Pan American report for Trinidad and Tobago showed a 51% raised risk for non-communicable lifestyle disease and the concomitant risk of cardiac disease in the 25–64-year age group with a reported increased rate of obesity, hypertension and diabetes (1).
Gamma-hydroxybutyrate (GHB) use became more prominent during the 1990s in various parts of the developed world. To date, no case of GHB use has been identified in Jamaica, though this drug is frequently used in other parts of the world at “raves” and other parties characterized by elaborate lights and fast-paced music. Here, a case of a 30-year old visitor to Jamaica is presented, highlighting the typical features of GHB withdrawal and the ease with which this party drug can be imported into the country.